Arrowhead Pharmaceuticals, Inc. (ARWR)
62.92
+0.28
(+0.45%)
USD |
NASDAQ |
Feb 10, 16:00
62.03
-0.89
(-1.41%)
Pre-Market: 09:17
Arrowhead Pharmaceuticals Total Assets (Quarterly) : 1.604B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 3.493B |
| Eli Lilly & Co. | -- |
| Ionis Pharmaceuticals, Inc. | 3.033B |
| Sanofi | -- |
| Cidara Therapeutics, Inc. | 518.65M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.041B |
| Shareholders Equity (Quarterly) | 568.42M |
| Debt to Equity Ratio | 1.21 |
| Current Ratio | 3.380 |
| Net Debt Paydown Yield | 0.36% |